Enlace externo, por favor revise nuestro descargo de responsabilidad (en inglés).

Serie de reportes de investigación: Abuso de la marihuana

Referencias

  1. Barnwell, S.S.; Earleywine, M. y Wilcox, R. Cannabis, motivation, and life satisfaction in an internet sample. Subst Abuse Treat Prev Policy 1:2, 2006.
  2. Caspi, A.; Moffitt, T.E.; Cannon, M.; McClay, J.; Murray, R.; Harrington, H.; Taylor, A.; Arseneault, L.; Williams, B.; Braithwaite, A.; Poulton, R. y Craig, I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57(10):1117–1127, 2005.
  3. Fergusson, D.M. y Boden, J.M. Cannabis use and later life outcomes. Addiction 103(6):969–976; discussion 977–968, 2008.
  4. Gouzoulis-Mayfrank, E. Dual diagnosis psychosis and substance use disorders: Theoretical foundations and treatment. Z Kinder Jugendpsychiatr Psychother 36(4):245–253, 2008.
  5. Hall, W. y Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391, 2009.
  6. Hashibe, M.; Morgenstern, H.; Cui, Y.; Tashkin, D.P.; Zhang, Z.F.; Cozen, W.; Mack, T.M. y Greenland, S. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 15(10):1829–1834, 2006.
  7. Klein, T.W. y Cabral, G.A. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol 1(1):50–64, 2006.
  8. Macleod, J.; Oakes, R.; Copello, A.; Crome, I.; Egger, M.; Hickman, M.; Oppenkowski, T.; Stokes-Lampard, H. y Davey Smith, G. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 363(9421): 1579–1588, 2004.
  9. Mukamal, K.J.; Maclure, M.; Muller, J.E. y Mittleman, M.A. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 155(3):465–470, 2008.
  10. O'Malley, P.M. y Johnston, L.D. Drugs and driving by American high school seniors, 2001–2006. J Stud Alcohol Drugs 68(6):834–842, 2007.
  11. Polen, M.R.; Sidney, S.; Tekawa, I.S.; Sadler, M. y Friedman, G.D. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158(6):596–601, 1993.
  12. Richer, I. y Bergeron, J. Driving under the influence of cannabis: Links with dangerous driving, psychological predictors, and accident involvement. Accid Anal Prev 41(2): 299–307, 2009.
  13. Schempf, A.H. y Strobino, D.M. Illicit drug use and adverse birth outcomes: Is it drugs or context? J Urban Health 85(6):858–873, 2008.
  14. Schweinsburg, A.D.; Brown, S.A. y Tapert, S.F. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev 1(1):99–111, 2008.
  15. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. HHS Pub. No. SMA 10-4856, Rockville, MD.: SAMHSA, 2010.
  16. Timberlake, D.S. A comparison of drug use and dependence between blunt smokers and other cannabis users. Subst Use Misuse 44(3): 401–415, 2009.
  17. Trezza, V.; Campolongo, P.; Cassano, T.; Macheda, T.; Dipasquale, P.; Carratu, M.R.; Gaetani, S.; Cuomo, V. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: A longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) 198(4): 529–537, 2008.

Página actualizada en mayo del 2011.

Serie de reportes de investigación

Esta serie de reportes, dirigida al público en general, los legisladores, los grupos educativos y los profesionales de la salud, explica la ciencia detrás de los resultados de la investigación.  La serie informa sobre los resultados de las investigaciones de interés nacional.

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site